SCHEMBL29198250

SCHEMBL29198250

O=c1[nH]c2ccccc2n1[C@H]1CC[C@@H](C(=O)O)CC1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 4/20 0.59
OPRK1 P41145 2/20 0.59
OPRL1 P41146 2/20 0.59
CHRM1 P11229 5/20 0.58
CHRM2 P08172 3/20 0.58
CHRM4 P08173 3/20 0.58
CHRM3 P20309 2/20 0.58
ALDH1A1 P00352 2/20 0.57
KDM4E B2RXH2 1/20 0.57
PMP22 Q01453 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57
SLC18A3 Q16572 1/20 0.56
HSD11B1 P28845 1/20 0.56
TNKS O95271 1/20 0.56
MAPK1 P28482 1/20 0.55
PLD2 O14939 1/20 0.55
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
DRD2 P14416 1/20 0.53
KCNH2 Q12809 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29198253 1.00 OPRM1 (0.59) OPRM1OPRK1OPRL1CHRM1CHRM2
SCHEMBL319049 0.88 CHRM1 (0.70) OPRM1OPRK1OPRL1CHRM1CHRM2
SCHEMBL20302189 0.84 CHRM2 (0.55) OPRM1CHRM1CHRM2CHRM4CHRM3
SCHEMBL20334172 0.84 CHRM2 (0.55) OPRM1CHRM1CHRM2CHRM4CHRM3
SCHEMBL20334166 0.84 ALDH1A1 (0.54) OPRM1OPRK1OPRL1CHRM1CHRM2
SCHEMBL20302481 0.84 ALDH1A1 (0.54) OPRM1OPRK1OPRL1CHRM1CHRM2
SCHEMBL7511954 0.84 SLC18A3 (0.64) OPRM1OPRK1OPRL1CHRM1CHRM2
SCHEMBL16444494 0.82 ALDH1A1 (0.64) OPRM1OPRK1OPRL1CHRM1CHRM2
SCHEMBL16444493 0.82 ALDH1A1 (0.64) OPRM1OPRK1OPRL1CHRM1CHRM2
SCHEMBL1833332 0.82 HSD11B1 (0.68) OPRM1OPRK1OPRL1CHRM1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112074511-B Substituted benzodiazoles and their use in therapy 托马斯·黑勒戴药物研究基金会 2024-04-26 CN disclosed